Evidence map›Paper›PMID 36169175›Full record

ArticleInternational journal of oncology2022

Altered expression of the

Patrick Scicluna, Stefano Caramuta, Hanna Kjellin, Cheng Xu, Robin Fröbom, Monira Akhtar, Jiwei Gao, Hao Shi, Magnus Kjellman, Malin Almgren and 6 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Biology · 2026
    Article
  2. Effect of Anti-Müllerian Hormone on Oocytes In Vitro Maturation in Sheep.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Patrick SciclunaDepartment of Oncology‑Pathology, BioClinicum, Karolinska University Hospital, Karolinska Institutet, SE‑171 64 Solna, Sweden.
Stefano CaramutaDepartment of Oncology‑Pathology, BioClinicum, Karolinska University Hospital, Karolinska Institutet, SE‑171 64 Solna, Sweden.
Hanna KjellinDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Cheng XuDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Robin FröbomDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Monira AkhtarDepartment of Clinical Neuroscience, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Jiwei GaoDepartment of Oncology‑Pathology, BioClinicum, Karolinska University Hospital, Karolinska Institutet, SE‑171 64 Solna, Sweden.
Hao ShiDepartment of Oncology‑Pathology, BioClinicum, Karolinska University Hospital, Karolinska Institutet, SE‑171 64 Solna, Sweden.
Magnus KjellmanDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Malin AlmgrenDepartment of Clinical Neuroscience, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Anders HöögDepartment of Oncology‑Pathology, BioClinicum, Karolinska University Hospital, Karolinska Institutet, SE‑171 64 Solna, Sweden.
Jan ZedeniusDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Tomas J EkströmDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Robert BränströmDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE‑171 76 Stockholm, Sweden.
Weng-Onn LuiDepartment of Oncology‑Pathology, BioClinicum, Karolinska University Hospital, Karolinska Institutet, SE‑171 64 Solna, Sweden.
Catharina LarssonDepartment of Oncology‑Pathology, BioClinicum, Karolinska University Hospital, Karolinska Institutet, SE‑171 64 Solna, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormalities of the insulin‑like growth factor 2

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical AdenomaAdrenocortical CarcinomaMicroRNAsElectron Transport Complex IHumansInsulin-Like Growth Factor IINADUbiquinoneElectron Transport Complex IIGF2 protein, humanInsulin-Like Growth Factor IIMicroRNAsMIRN675 microRNA, humanNADUbiquinoneadrenal cortical tumorsH19insulin‑like growth factor 2microRNAsmitochondrial respiratory complexes

Identifiers

PMID36169175
PMCPMC9529429
OpenAlexW4297370988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.